In contrast, ChREBP inactivation, driven by inhibition of KHK which is essential for fructose metabolization, reverses fructose mediated hyperinsulinemia, hypertriglyceridemia and hepatic steatosis (103). This evidence concerns the gene MLXIPL and fatty liver disease.